Kumar Pramod, Singh Aarti, Kumar Anurag, Kumar Rahul, Pal Rishi, Sachan Amod Kumar, Dixit Rakesh Kumar, Nath Rajendra
Department of Pharmacology &Therapeutics King George's Medical University, Lucknow 226003, Uttar Pradesh, India.
Department of Pharmacology, King George Medical University, Lucknow 226003, Uttar Pradesh, India.
Biomedicines. 2023 May 11;11(5):1422. doi: 10.3390/biomedicines11051422.
The most frequent neurodegenerative illness among senior people and the main cause of dementia is Alzheimer's disease. The present dementia medications available only help with the symptoms of cognitive deficits and have several negative effects. The current study's goal is to assess the effects of curcumin and coenzyme Q10, two herbal medicines, both separately and in combination, on learning and memory before comparing them to the industry standard drug. A total of 42 adult healthy Wistar rats were used in our study. In this experiment, rats were given daily doses of 2.5 mg/kg of body weight of scopolamine hydrobromide for 7 days to induce Alzheimer's disease. On the eighth day, behavioural testing was conducted. Following testing, scopolamine and the test medications were given daily for the following 21 days. On days 29 and 30, behavioural testing was conducted once more, and then animals were slaughtered. Brain homogenate was produced for the estimation of molecular and biochemical markers. Curcumin has demonstrated a dose-response relationship, with a higher dose (200 mg/kg b.w. p.o.) being more effective than a lower dose (100 mg/kg b.w. p.o.). Similar to the greater dose of curcumin, coenzyme Q10 (200 mg/kg b.w. p.o.) has also been found to improve memory and learning. Higher doses of curcumin and coenzyme Q10 had more pronounced and meaningful effects. Acetylcholinesterase and TNF levels increased in scopolamine-induced memory impairment, but these effects were restored by the test medications, and improved by the combined therapy. These outcomes are comparable to those of the common medication memantine. As a result, we may infer from our results that curcumin at higher doses and its combination with coenzyme Q10 (200 mg/kg b.w. p.o.) have a significant impact on cognitive impairment in animal models of Alzheimer's disease and can be utilised alone or as an add-on therapy for the condition.
老年人中最常见的神经退行性疾病以及痴呆症的主要病因是阿尔茨海默病。目前可用的痴呆症药物仅有助于缓解认知缺陷症状,且有多种负面影响。本研究的目的是评估两种草药姜黄素和辅酶Q10分别及联合使用对学习和记忆的影响,然后将其与行业标准药物进行比较。我们的研究共使用了42只成年健康Wistar大鼠。在本实验中,大鼠连续7天每天给予2.5mg/kg体重的氢溴酸东莨菪碱以诱导阿尔茨海默病。第8天进行行为测试。测试后,在接下来的21天每天给予东莨菪碱和受试药物。在第29天和第30天再次进行行为测试,然后宰杀动物。制备脑匀浆以评估分子和生化标志物。姜黄素呈现出剂量反应关系,较高剂量(200mg/kg体重,口服)比较低剂量(100mg/kg体重,口服)更有效。与较高剂量的姜黄素类似,辅酶Q10(200mg/kg体重,口服)也被发现可改善记忆和学习。较高剂量的姜黄素和辅酶Q10具有更显著和有意义的效果。东莨菪碱诱导的记忆损伤中乙酰胆碱酯酶和TNF水平升高,但受试药物可恢复这些影响,联合治疗可改善这些影响。这些结果与常用药物美金刚的结果相当。因此,我们可以从结果中推断,较高剂量的姜黄素及其与辅酶Q10(200mg/kg体重,口服)的联合使用对阿尔茨海默病动物模型的认知损伤有显著影响,可单独使用或作为该疾病的附加疗法。